Skip to main content
    C

    Collplant Biotechnologies Ltd (CLGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.64
    +0.00 (+0.00%)

    Market Cap: $14.27M

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Collplant Biotechnologies Ltd (CLGN) Stock Chart

    Updated Nov 16, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Collplant Biotechnologies (CLGN) closed at $4.64 on Nov 16, 2026, 79.4% below its 52-week high of $22.50. Its price fell 76.6% over the past 12 months. The month-end price fell 95.4% since Jan 2018, a compound annual decline of 29.6%.

    Price Chart

    From Jan 2018 to Oct 2026, its highest month-end close was $220.00 in Oct 2021 and its lowest $2.73 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CLGN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLGN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 47.6%, and over 6 months it rose 6.7%. The month-end price fell 92.3% over the 3 years through Oct 2026, a compound annual decline of 57.4%.

    PeriodChange
    1 month+28.0%
    3 months+47.6%
    6 months+6.7%
    12 months-76.6%
    12 months, with dividends-76.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-92.3%-57.4%
    5 years-98.1%-54.8%
    Since Jan 2018-95.4%-29.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 88.9%, and its weakest was 2025, when it fell 61.1%.

    YearCloseChange
    2026 through Oct 2026$4.13-70.5%
    2025$14.00-61.1%
    2024$36.00-43.7%
    2023$63.90-23.5%
    2022$83.50-49.0%
    2021$163.60+51.9%
    2020$107.70+88.9%
    2019$57.00+35.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 19.4% above its 50-day average of $3.89 and 5.6% above its 200-day average of $4.40.

    MeasureValuePrice vs
    Close (Nov 16, 2026)$4.64
    52-week high$22.50-79.4%
    52-week low$2.64+76.0%
    50-day average$3.89+19.4%
    200-day average$4.40+5.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 96.0%.

    MeasureValue
    1-year beta1.39
    Largest fall, 1 year-87.8%
    Largest fall, 3 years-96.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CLGN

    What is CLGN's 1-year price change?

    Collplant Biotechnologies's price fell 76.6% over the past 12 months. With dividends included, the 12-month total return was -76.6%.

    What is CLGN's 5-year price change?

    Collplant Biotechnologies's month-end price fell 98.1% over the 5 years through Oct 2026, a compound annual decline of 54.8%. These figures leave out dividends.

    What is CLGN's 52-week high and low?

    Collplant Biotechnologies's 52-week high is $22.50 and its 52-week low is $2.64. Its close of $4.64 on Nov 16, 2026 is 79.4% below the high.

    What is CLGN's beta?

    Collplant Biotechnologies's 1-year beta against the S&P 500 is 1.39, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.8%.

    Is the CLGN chart free?

    Yes. Advanced Charting for CLGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.